Exhibit Hall Theater Talks
Cell therapy has emerged as a promising approach of leveraging the potential of living cells to treat a variety of diseases such as Cancer, Autoimmune diseases, and Neurological disorders. Expansion and/or differentiation of cells with the right therapeutic profiles, in a consistent and safe manner, requires the use of defined cell isolation, culture and handling reagents manufactured under GMP conditions. One major cause of variability is serum or serumderived component, with its undefined composition. The presence of undefined reagents can lead to the inability to reproduce results between labs and stop the progression from discoveries to clinical applications. Here we introduce critical GMP-grade, serum-free ancillary reagents such as magnetic bead-based cell isolation kits, xeno-free media for both immune (T & NK) & stem/progenitor cells as well as chemically defined cryopreservation solution specially designed for therapeutic development & manufacturing. Our development work has allowed us to gain in depth knowledge of the impact of each component in primary cell biology, allowing us at BioLegend to provide custom tailored solutions. The development of defined reagents provides a smooth transition and reproducibility between research and clinical development.